Cargando…
Mechanisms of EGFR Resistance in Glioblastoma
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. Despite numerous efforts to target epidermal growth factor receptor (EGFR), commonly dysregulated in GBM, approaches directed against EGFR have not achieved the same degree of success as seen in other tumor types, particu...
Autores principales: | Pan, Peter C., Magge, Rajiv S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696540/ https://www.ncbi.nlm.nih.gov/pubmed/33187135 http://dx.doi.org/10.3390/ijms21228471 |
Ejemplares similares
-
Advances in Radiotherapy for Glioblastoma
por: Mann, Justin, et al.
Publicado: (2018) -
Improved Pathologic Diagnosis—Forecasting the Future in Glioblastoma
por: Pisapia, David J., et al.
Publicado: (2017) -
An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma
por: Rodriguez, Silvia Mara Baez, et al.
Publicado: (2023) -
Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
por: Azuaje, Francisco, et al.
Publicado: (2015) -
Mechanisms of resistance to EGFR tyrosine kinase inhibitors
por: Huang, Lihua, et al.
Publicado: (2015)